Current and future medical costs of asthma and chronic obstructive pulmonary disease in the Netherlands

Respiratory Medicine

Volumn 93, Issue 11, 1999, Pages 779-787

  Rutten Van Molken M P M H ^a   Postma, M J ^b   Joore, M A ^c   Van Genugten, M L L ^b   Leidl, R ^d   Jager, J C ^b  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT;

ADOLESCENT; ADULT; AGED; AGING; ARTICLE; ASTHMA; CHILD; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG COST; FEMALE; HEALTH CARE COST; HEALTH CARE PLANNING; HUMAN; INCIDENCE; INFANT; MALE; MIGRATION; MORTALITY; NETHERLANDS; PREDICTION; PRIORITY JOURNAL; SMOKING; SMOKING CESSATION;

EID: 0032700484     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(99)90262-7     Document Type: Article

References (37)

1. National Institutes of Health. National Heart, Lung and Blood Institute. Global initiative for asthma. Global strategy for asthma management and prevention. Workshop Report 95-3659. January 1995
2. Krahn MD, Berka C, Langloid P, Detsky AS. Direct and indirect costs of asthma in Canada, 1990. Can Med Assoc J 1996; 154: 821-831.
3. Sullivan SD. Cost-effectiveness of drug interventions. Eur Respir Rev 1996; 6(35): 116-118.
4. Barnes PJ, Jönsson B, Klim JB. The costs of asthma. Eur Respir J 1996; 9: 636-642.
5. Jacobsson L, Lindgren B. Samhalls ekonomiska kostnaderna for kroniskt obstruktiv lung sjukdom. Lund University, Institute for Economic Research, 1995 (In Swedish).
6. Weiss KB. An overview of recent trends in asthma epidemiology. Eur Respir Rev 1996; 6: 101-104.
7. Löfdahl C-G. Cost development of obstructive airway disease in Sweden. Eur Respir Rev 1996; 35: 113-115.
8. Organisation for Economic Co-operative and Development (OECD), CD ROM Health Database, Paris, 1997.
9. Financieel Overzicht Zorg 1995, Sdu Uitgeverij, 's Gravenhage, 1995 (in Dutch).
10. Statistics Netherlands. Health Interview Survey. Specific queries on physician contacts by age, gender and diagnosis, 1992-1994, Heerlen, 1997.
11. Statistics Netherlands. Netherlands Health Interview Survey 1981-1995. The Hague: SDU publishers. CBS-publications, 1996.
12. Rutten FFH, Van Ineveld BM, Van Ommen R, Van Hout BA, Huijsmas R. Stuurgroep Toekomstscenario's Gezondheidszorg. Kostenberekening bij Gezondheidszorg-onderzoek. Richtlijnen voor de praktijk. Jan van Arket, Utrecht, 1993 (In Dutch).
13. Verkleij H, Casparie AF. Chronische Ziekten in het jaar 2005 (deel 2); scenario's over CARA 1990-2005. Bohn Stafleu van Loghum. Houten/Antwerpen, 1990 (In Dutch).
14. SIG Health Care Information. National Medical Registration 1993; Utrecht, SIG, 1994.
15. SIG Health Care Information. Annual Report on Nursing Homes 1993; Utrecht, SIG, 1994.
16. NZI (National Hospital Institute). Financial Statistics 1993; General Hospitals. Utrecht, 1993.
17. NZI (National Hospital Institute). Financial Statistics 1993; University Hospitals. Utrecht, 1993.
18. NZI (National Hospital Institute). Financial Statistics 1993; Categorical Hospitals. Utrecht, 1993.
19. NZI (National Hospital Institute). Financial Statistics 1993; Nursing Homes for Somatic Illnesses. Utrecht, 1993.
20. Leufkens, Haayer-Ruskamp, Bakker. De toekomst van het geneesmiddel in de gezondheidszorg. Een scenarioanalyse. Stuurgroep Toekomstscenarios Gezondheidszorg. Bohn Stafleu Van Loghum, Houten/Zavetem, 1993 (In Dutch).
21. Van Genugten MLL, Hoogenveen RT, De Hollander AEM. Incorporating Risk Factor Epidemiology in Mortality Projections for the Next Century. In: Tabeau E, Van den Berg Jeths A, Healthcote C, eds. Forecasting of Mortality in Developed Countries: searching for better methods and realistic assumptions (In press).
22. StiVoRo. Jaarverslag 1996. Den Haag: Stichting Volksgenzondheid en Roken, 1997 (In Dutch).
23. Van de Lisdonk EH, Van den Bosch WJHM, Huygen FJA, Lagro-Jansen ALM. Ziekten in de Huisartspraktijk. Wetenscahappelijke Uitgeverij Bunge, Utrecht, 1994 (In Dutch).
24. Hoogenveen RT, Van Genugten MLL, De Hollander AEM. The chronic diseases modelling approach. RIVM-report 266750001, Bilthoven, 1998.
25. Shopland DR, Harmon JE, Fechacek TF. Smoking attributable cancer mortality in 1991: is lung cancer now the leading cause of death among smokers in the United States: J Natl Cancer Inst 1991; 83: 1142-1148.
26. US DHHS (US Department of Health and Human Services): The health benefits of smoking cessation. A report of the surgeon general. Washington DC: US DHHS, Public Health (Office on Smoking and Health), Washington, 1990.
27. Burrows B. The natural history of asthma. J Allergy Immunol 1987; 3: 373-377.
28. Van Genugten MLL, Hoogenveen RT, Mulder I, Smit HA, Jansen J, De Hollander AEM. The effectiveness of different policies to reduce tobacco smoking prevalence and disease burden. (Submitted).
29. Viswevaran C, Schmidt FL. A meta-analysis comparison of the effectiveness of smoking cessation methods. J Applied Psych 1992; 77: 554-561.
30. Fisher KJ, Glasgow RE, Terborg JR. Worksite smoking cessation: a meta-analysis of long-term quit rates from controlled studies. J Occup Med 1990; 32: 429-439.
31. Mullen PD, Ramirez G, Groff JY. A meta-analysis of randomized trials of prenatal smoking cessation interventions. Am J Obstet Gynecol 1994; 171: 1328-1334.
32. Polder JJ, Meerding WJ, Koopmacschap MA, Bonneux L, Van der Maas PJ. Kosten van ziekten in Nederland 1994. Instituut Maatscappelijke Gezondheidszorg, Instituut voor Meidsche Technology Assessment, Erasmus Universiteit Rotterdam, Rotterdam, 1997 (In Dutch).
33. Van Schayck CP. Het einde van de term CARA in zieht? Ned Tijdschr Geneeskd 1994; 138: 1405-1408. (In Dutch).
34. Statistics Netherlands. Statline, the statistical database on the Netherlands, CBS, Voorburg, Heerlen, 1998.
35. Rutten-van Mölken MPMH, Van Doorslaer EKA, Jansen CCM, Kerstjens HAM, Rutten FFH, Costeffectiveness of inhaled corticosteroid and bronchodilator therapy in asthma and COPD. Am Rev Respir Crit Care Med 1995; 151: 975-982.
36. Gibson PG, Coughlan J, Wilson AJ, Abramson M, Bauman A, Hensley MJ, Walters EH. Self-management education and regular practitioner review for adults with asthma (Cochrane Review). In: The Cochrane Library, Issuel, 1999. Oxford: Update Software.
37. Barendregt JJ, Bonneux L, Van der Maas PJ. The Health Care Costs of Smoking. N Eng J Med 1997; 337: 1052-1057.